Zevra Therapeutics, Inc. financial data

Symbol
ZVRA on Nasdaq
Industry
Pharmaceutical Preparations
Location
1180 Celebration Boulevard, Suite 103, Celebration, FL
State of incorporation
DE
Fiscal year end
December 31
Former names
KEMPHARM, INC (to 2/24/2023), KEMPHARM INC (to 6/30/2011)
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 223 % -68.6%
Debt-to-equity 194 % +302%
Return On Equity -131 % -462%
Return On Assets -44 % -195%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 52.6M shares +55.1%
Common Stock, Shares, Outstanding 42M shares +23.8%
Entity Public Float 172M USD +12.6%
Common Stock, Value, Issued 4K USD +33.3%
Weighted Average Number of Shares Outstanding, Basic 41.9M shares +23.6%

Income Statement

Label TTM Value / Value Unit Change %
Cost of Revenue 2.95M USD +1227%
Research and Development Expense 11M USD +22.2%
General and Administrative Expense 15.3M USD +76.3%
Costs and Expenses 92.5M USD +82.2%
Operating Income (Loss) -74.8M USD -114%
Nonoperating Income (Expense) 8.17M USD -56.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -66.6M USD -313%
Income Tax Expense (Benefit) 177K USD -65.2%
Net Income (Loss) Attributable to Parent -66.8M USD -301%
Earnings Per Share, Basic -1.72 USD/shares -251%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 39.3M USD -40.7%
Marketable Securities, Current 1.34M USD
Cash, Cash Equivalents, and Short-term Investments 67.7M USD
Accounts Receivable, after Allowance for Credit Loss, Current 16.1M USD +124%
Inventory, Net 9.84M USD +1367%
Assets, Current 60.9M USD -41.1%
Other Long-term Investments 0 USD -100%
Property, Plant and Equipment, Net 678K USD -1.6%
Operating Lease, Right-of-Use Asset 911K USD +13.5%
Intangible Assets, Net (Excluding Goodwill) 66.2M USD
Goodwill 4.7M USD
Other Assets, Noncurrent 875K USD +1551%
Assets 144M USD +36.9%
Accounts Payable, Current 14M USD +287%
Accrued Liabilities, Current 0 USD -100%
Liabilities, Current 30.4M USD +66.8%
Operating Lease, Liability, Noncurrent 544K USD -13.2%
Other Liabilities, Noncurrent 6.64M USD +1994%
Liabilities 112M USD +202%
Accumulated Other Comprehensive Income (Loss), Net of Tax 421K USD
Retained Earnings (Accumulated Deficit) -436M USD -34.1%
Stockholders' Equity Attributable to Parent 32.5M USD -44.8%
Liabilities and Equity 144M USD +36.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -16.2M USD -300%
Net Cash Provided by (Used in) Financing Activities 1.22M USD
Net Cash Provided by (Used in) Investing Activities 14.8M USD
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 43.6M shares +22.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -200K USD +99.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 140K USD +106%
Deferred Tax Assets, Valuation Allowance 134M USD +64.3%
Deferred Tax Assets, Gross 149M USD +81.4%
Operating Lease, Liability 1.14M USD +5.26%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -66.2M USD -292%
Lessee, Operating Lease, Liability, to be Paid 1.33M USD +12.4%
Property, Plant and Equipment, Gross 2.37M USD +5.95%
Operating Lease, Liability, Current 596K USD +30.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 141K USD -63.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 532K USD +9.02%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure +13.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 188K USD +89.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 130K USD +333%
Deferred Tax Assets, Operating Loss Carryforwards 90.7M USD +36.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 154K USD
Operating Lease, Payments 123K USD -13.4%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 1.5M USD
Depreciation, Depletion and Amortization 1.56M USD +1877%
Share-based Payment Arrangement, Expense 9.01M USD +153%
Interest Expense 2.05M USD +301%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%